Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00743730 · ClinicalTrials.gov registry record · NA
Parent Nurse Controlled Analgesic in Pediatric Patients With Developmental Delay
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT00743730: Completed NA study, sponsored by Medical College of Wisconsin.
NCT00743730 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 94 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00743730, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
The purpose of this study is to compare, the safety, efficacy and level of parent and nurse satisfaction with three methods of opioid administration post-operatively in children (4-18 years of age) with developmental delay.
Primary Outcome
Pain is measured with the Face, Legs, Activity, Cry, Consolability scale (FLACC) is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. The median pain score over the first shift (24 hours) is reported.
Interventions
- OTHER Pain and standard side effect management for PNCA with basal method.
- OTHER Pain and standard side effect management with PNCA without basal
- OTHER Pain and standard side effect management with IV on an as needed basis method.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2005-06 |
| Est. Completion | 2010-02 |
| Phase | NA |
What the finished NCT00743730 record still lists
NCT00743730 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Pain and standard side effect management for PNCA with basal method. is the first listed.
NCT00743730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00743730 about?
NCT00743730 is a clinical study titled "Parent Nurse Controlled Analgesic in Pediatric Patients With Developmental Delay". The purpose of this study is to compare, the safety, efficacy and level of parent and nurse satisfaction with three methods of opioid administration post-operatively in children (4-18 years of age) with developmental delay.
What is the current status of trial NCT00743730?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2005-06. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00743730?
The interventions under investigation include: Pain and standard side effect management for PNCA with basal method. (OTHER), Pain and standard side effect management with PNCA without basal (OTHER), Pain and standard side effect management with IV on an as needed basis method. (OTHER).
Who is sponsoring clinical trial NCT00743730?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00743730's enrollment target sits among peer trials
94 935th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia